Checklists Resuscitation Emergency Department

Clinical Use of an Emergency Manual by Resuscitation Teams and Impact on Performance in the Emergency Department

The study will systematically evaluate how an emergency manual-a collection of checklists and fact sheets-affects the performance of resuscitation teams during the management of priority one patients in an emergency department.

Study Overview

• Status: Not yet recruiting
• Conditions: Pneumonia; Burns; Shock; Poisoning; Abdominal Pain; Chest Pain; Trauma; Fever; Bradycardia; Syncope; Seizures; Vertigo; Tachycardia; Cardiac Arrest; Diabetic Ketoacidosis; Shortness of Breath; Allergic Reaction; Asthma Acute; Altered Mental Status; COPD Exacerbation Acute; Pulmonary Edema - Acute; Hyperglycemic Hyperosmolar Nonketotic Syndrome
• Intervention / Treatment: Other: Emergency Manual

Detailed Description

Simulation-based studies indicate that crisis checklist use improves management of patients with critical conditions in the emergency department (ED). This six-month-long study prospectively evaluates a digital emergency manual-a collection of crisis checklists and fact sheets-during the management of priority 1 patients in the Skåne University Hospital at Lund's ED.

• Study Type: Interventional
• Enrollment (Anticipated): 2000
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Eric Dryver, MD; Phone Number: +46-738-198261; Email: eric.dryver@med.lu.se
• Study Contact Backup: Name: Ulf Ekelund, MD PhD; Phone Number: +46-702-049480; Email: ulf.ekelund@med.lu.se

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult; Older Adult
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Consecutive priority 1 patients managed in the resuscitation room of Skåne University Hospital at Lund's Emergency Department

Exclusion Criteria:

• None

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Patients managed with Emergency Manual access; Consecutive priority 1 patients managed by resuscitation teams with access to an Emergency Manual	Other: Emergency Manual; Collection of crisis checklists and fact sheets

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Degree of indication of interventions performed thanks to Do-Confirm Emergency Manual use	The primary outcome measures are the proportions of interventions performed thanks to Do-Confirm EM use graded as indicated, of neutral relevance, and not indicated.	1 hour

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Team's subjective evaluation of Emergency Manual value	The team's subjective evaluation of the EM's value is recorded prior to the logging out from the EM using a Likert scale of 1 to 6.	1 hour
Degree of indication of interventions that might have been performed had the Emergency Manual been used	Fifty patients that presented during the six-month period preceding EM implementation, are identified. These 50 patients are selected based on matching to the 50 patients where the EM was used, using age, presenting complaint and relevant co-morbidities. In addition, fifty patients where the EM was not used during the pilot study period are also identified based on the same matching process. The EM is accessed to determine whether additional interventions would have been performed, had the EM been used. All interventions-those actually performed as well as those that might have been performed had the EM been used-are then assessed for degree of indication by three external reviewers.	1 hour
Structured interviews	Teams can electronically request contact with the investigators to report specific events related to EM use. If so, the following data is extracted during a structured interview: patient age, sex, presenting complaint and suspected diagnosis; seniority of the physician initially in charge of the case; events or concerns relating to EM use; mode of EM use (Do-Confirm, Read-Do, Sampling) and sections relevant to the case; personnel's assessment of the impact of the EM on patient care; personnel's assessment of impact of the EM on team members and teamwork; personnel's suggestions for EM improvement	Up to 8 weeks

Collaborators and Investigators

• Sponsor: Region Skane
• Investigators: Principal Investigator: Eric Dryver, MD, Skane's University Hospital in Lund, Emergency Department

Study record dates

Study Major Dates

• Study Start (Anticipated): September 1, 2023
• Primary Completion (Anticipated): March 1, 2024
• Study Completion (Anticipated): March 1, 2024

Study Registration Dates

• First Submitted: November 21, 2022
• First Submitted That Met QC Criteria: December 5, 2022
• First Posted (Actual): December 14, 2022

Study Record Updates

• Last Update Posted (Actual): December 14, 2022
• Last Update Submitted That Met QC Criteria: December 5, 2022
• Last Verified: December 1, 2022

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Chemically-Induced Disorders; Pathologic Processes; Heart Diseases; Cardiovascular Diseases; Glucose Metabolism Disorders; Metabolic Diseases; Nervous System Diseases; Respiratory Tract Diseases; Immune System Diseases; Respiration Disorders; Lung Diseases; Pain; Neurologic Manifestations; Neurobehavioral Manifestations; Endocrine System Diseases; Disease Attributes; Signs and Symptoms, Digestive; Diabetes Complications; Diabetes Mellitus; Otorhinolaryngologic Diseases; Labyrinth Diseases; Ear Diseases; Signs and Symptoms, Respiratory; Arrhythmias, Cardiac; Cardiac Conduction System Disease; Vestibular Diseases; Unconsciousness; Consciousness Disorders; Acid-Base Imbalance; Acidosis; Hypersensitivity; Emergencies; Poisoning; Chest Pain; Abdominal Pain; Bradycardia; Seizures; Vertigo; Tachycardia; Syncope; Pulmonary Edema; Dyspnea; Ketosis; Diabetic Ketoacidosis
• Other Study ID Numbers: 2022-01896-01

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: No

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No